CPT 0540F: Glucocorticoid Management Plan for Rheumatoid Arthritis

CPT code 0540F denotes a documented glucocorticoid management plan that specifies monitoring of the duration and dosing of glucocorticoid therapy for patients with rheumatoid arthritis. This measure captures a focused medication-management activity intended to limit prolonged or high-dose steroid exposure and to document a clinician’s plan for monitoring and tapering when appropriate. Nationally, the code matters as payers and quality programs increasingly emphasize structured plans for potentially high-risk medications.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical intent and service setting, plus an outline of the typical documentation elements tied to the measure. The publication summarizes common billing considerations, expected sites of service, and the clinical context of glucocorticoid stewardship in RA care. It also highlights where data is unavailable in the input, such as specific modifiers, associated taxonomies, ICD-10 diagnoses, related codes, and payer-specific billing guidance. The material is written for a national audience of clinicians, coders, and policy analysts seeking clarity on the purpose and practical use of 0540F in rheumatology medication management.

Billing Code Overview

CPT code 0540F is reported when a provider develops and documents a glucocorticoid management plan to monitor the length and dose of a glucocorticoid used to treat rheumatoid arthritis (RA) in a patient. The code represents a documented care-planning activity focused on safe, time-bound glucocorticoid use as part of RA management.

Service type: Care planning and medication management

Typical site of service: Outpatient clinic or office-based rheumatology practice, where documentation of treatment plans and medication monitoring ordinarily occurs.

Clinical Context

A 58-year-old woman with established seropositive rheumatoid arthritis presents to a rheumatology clinic for routine follow-up. She has intermittent flares controlled on disease-modifying antirheumatic drugs (DMARDs) but requires short courses of oral glucocorticoids for acute symptom control. The provider documents a glucocorticoid management plan that specifies the indication for glucocorticoid use, the starting dose, planned taper schedule, maximum cumulative duration, monitoring parameters for adverse effects (blood pressure, glucose, bone health), and criteria for reassessment or referral to endocrinology. The plan is recorded in the progress note, communicated to the patient, and incorporated into the medication reconciliation and patient education materials. Typical workflow includes medication review, assessment of flare severity, shared decision-making about steroid duration and dose, documentation of the written plan, and scheduling appropriate monitoring (e.g., bone density assessment, metabolic labs). Typical site of service is an outpatient rheumatology clinic or ambulatory care setting. Service type is clinical evaluation and management with documented chronic medication management planning for glucocorticoids in rheumatoid arthritis.

Coding Specifications

Modifier	Description	When to Use
`25`	Significant, separately identifiable E/M service by the same physician on the same day of the procedure	Use when an unrelated E/M visit is performed the same day as a procedure or service and both are documented separately.

Taxonomy Code	Specialty	Notes
207R00000X	Rheumatology	Specialists who most commonly develop and document glucocorticoid management plans for RA.
207L00000X	Internal Medicine	Primary care physicians who co-manage chronic RA and glucocorticoid use.
208000000X	Family Medicine	Family physicians who manage chronic inflammatory conditions and steroid plans in ambulatory settings.
363A00000X	Nurse Practitioner	Advanced practice providers who frequently document medication management plans in clinic.
364S00000X	Physician Assistant	PAs who participate in chronic disease management and documentation of steroid taper plans.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`M05.79`	Rheumatoid arthritis with rheumatoid factor, multiple sites without organ or system involvement	Represents seropositive RA that commonly requires disease-modifying therapy and intermittent glucocorticoid courses; justification for a steroid management plan.
`M06.9`	Rheumatoid arthritis, unspecified	General diagnosis for RA patients who may require glucocorticoids for flare management and require documented steroid plans.
`M06.0`	Rheumatoid arthritis with rheumatoid factor	Denotes RA subtype often requiring close medication management, including glucocorticoid use.
`M05.89`	Rheumatoid arthritis with rheumatoid factor of other specified sites	Site-specific RA diagnoses that still warrant systemic glucocorticoid management planning.
`M12.9`	Arthropathy, unspecified	Used less commonly but may appear in differential diagnoses where steroid management could be considered.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Common E/M code used for a routine follow-up visit during which a glucocorticoid management plan may be developed and documented.
`99406`	Smoking and tobacco use cessation counseling visit, intermediate, greater than 3 minutes up to 10 minutes	May be performed during the same visit to address modifiable risk factors that affect steroid-related complications (e.g., bone health); counseling codes used adjunctively when documented separately.
`77080`	Dual-energy X-ray absorptiometry (DXA), bone density study	Often ordered to assess bone health prior to or during chronic glucocorticoid therapy and may be part of the monitoring plan.
`96372`	Therapeutic, prophylactic, or diagnostic injection (e.g., steroid injection), subcutaneous or intramuscular	Procedure code for a steroid injection that may be part of RA flare management distinct from the oral glucocorticoid plan; documentation must distinguish injection from the medication management plan.
`99497`	Advance care planning including the explanation and discussion of advance directives, first 30 minutes	May be used in complex chronic disease visits where goals of care and risks of long-term steroids are discussed and documented.

OpenPayer

Summary & Overview